GABELLI FUNDS LLC - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 115 filers reported holding INTERSECT ENT INC in Q3 2020. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2022$8,624,000
+35.7%
307,884
+32.3%
0.06%
+42.5%
Q4 2021$6,355,000
+29.6%
232,682
+29.1%
0.04%
+25.0%
Q3 2021$4,903,000
+1764.3%
180,254
+1069.6%
0.03%
+1500.0%
Q2 2021$263,000
-18.8%
15,411
-0.6%
0.00%0.0%
Q1 2021$324,000
-46.6%
15,500
-41.5%
0.00%
-50.0%
Q4 2020$607,000
-8.6%
26,500
-34.9%
0.00%
-20.0%
Q3 2020$664,00040,6980.01%
Other shareholders
INTERSECT ENT INC shareholders Q3 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 700,000$11,963,0002.51%
First Light Asset Management, LLC 2,210,970$37,785,0002.27%
Altium Capital Management LP 182,456$3,118,0000.72%
Rock Springs Capital Management LP 1,220,000$20,850,0000.41%
Novo Holdings A/S 508,922$8,697,0000.39%
PURA VIDA INVESTMENTS, LLC 531,229$9,079,0000.28%
Eversept Partners, LP 175,389$2,997,3980.20%
Polar Asset Management Partners Inc. 801,628$13,700,0000.14%
HighMark Wealth Management LLC 9,575$164,0000.12%
Bellevue Group AG 617,968$10,561,0000.10%
View complete list of INTERSECT ENT INC shareholders